Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The study is to compare the rate and extent of absorption of a generic formulation with that of a reference for mulation when given as equal labeled dose. The study will be randomized, open-label, single dose, two way crossover design with two-period, two-treatment and two-sequence under fed condition and at least 7 days washout period between the doses.
Epistemonikos ID: 29d8a64c19af0f13b5093c51d09e684a69da22cc
First added on: May 15, 2024